Pharmacological therapies for the prevention of fractures in men

0Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the benefits and harms of bisphosphonates, parathyroid or parathyroid-related protein analogues, denosumab, and romosozumab therapy for the primary and secondary prevention of fractures in men.

Cite

CITATION STYLE

APA

Braten, L. C., Johnston, R. V., Suter, C., Saku, S., Järvinen, T., & Buchbinder, R. (2021). Pharmacological therapies for the prevention of fractures in men. Cochrane Database of Systematic Reviews, 2021(8). https://doi.org/10.1002/14651858.CD014707

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free